-
1
-
-
0030665020
-
The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours
-
Verrill MW, Judson IR, Wiltshaw E, Thomas JM, Harmer CL, Fisher C. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol. 1997; 8: 1099-1105.
-
(1997)
Ann Oncol
, vol.8
, pp. 1099-1105
-
-
Verrill, M.W.1
Judson, I.R.2
Wiltshaw, E.3
Thomas, J.M.4
Harmer, C.L.5
Fisher, C.6
-
2
-
-
34447324657
-
The Biology of Ewing sarcoma
-
Riggi N, Stamenkovic I. The Biology of Ewing sarcoma. Cancer Lett. 2007; 254: 1-10.
-
(2007)
Cancer Lett.
, vol.254
, pp. 1-10
-
-
Riggi, N.1
Stamenkovic, I.2
-
3
-
-
47249160783
-
Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future
-
Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol. 2008; 20: 412-418.
-
(2008)
Curr Opin Oncol.
, vol.20
, pp. 412-418
-
-
Ludwig, J.A.1
-
4
-
-
47549083691
-
Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data
-
Esiashvili N, Goodman M, Marcus RB, Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data. J Pediatr Hematol Oncol. 2008; 30: 425-430.
-
(2008)
J Pediatr Hematol Oncol.
, vol.30
, pp. 425-430
-
-
Esiashvili, N.1
Goodman, M.2
Marcus, R.B.3
-
5
-
-
84889039386
-
Targeted therapy in Ewing sarcoma
-
Lissat A, Chao MM, Kontny U. Targeted therapy in Ewing sarcoma. ISRN Oncol. 2012; 2012: 609439.
-
(2012)
ISRN Oncol.
, vol.2012
, pp. 609439
-
-
Lissat, A.1
Chao, M.M.2
Kontny, U.3
-
6
-
-
33749169684
-
Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors
-
Hunold A, Weddeling N, Paulussen M, Ranft A, Liebscher C, Jurgens H. Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors. Pediatr Blood Cancer. 2006; 47: 795-800.
-
(2006)
Pediatr Blood Cancer.
, vol.47
, pp. 795-800
-
-
Hunold, A.1
Weddeling, N.2
Paulussen, M.3
Ranft, A.4
Liebscher, C.5
Jurgens, H.6
-
7
-
-
77954727583
-
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial
-
Ladenstein R, Potschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, van den Berg H, Dirksen U, Hjorth L, Michon J, Lewis I, Craft A, Jurgens H. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol. 2010; 28: 3284-3291.
-
(2010)
J Clin Oncol.
, vol.28
, pp. 3284-3291
-
-
Ladenstein, R.1
Potschger, U.2
Le Deley, M.C.3
Whelan, J.4
Paulussen, M.5
Oberlin, O.6
van den Berg, H.7
Dirksen, U.8
Hjorth, L.9
Michon, J.10
Lewis, I.11
Craft, A.12
Jurgens, H.13
-
8
-
-
62449230721
-
Identification of cancer stem cells in Ewing's sarcoma
-
Suva ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, Suva D, Clement V, Provero P, Cironi L, Osterheld MC, Guillou L, Stamenkovic I. Identification of cancer stem cells in Ewing's sarcoma. Cancer Res. 2009; 69: 1776-1781.
-
(2009)
Cancer Res.
, vol.69
, pp. 1776-1781
-
-
Suva, M.L.1
Riggi, N.2
Stehle, J.C.3
Baumer, K.4
Tercier, S.5
Joseph, J.M.6
Suva, D.7
Clement, V.8
Provero, P.9
Cironi, L.10
Osterheld, M.C.11
Guillou, L.12
Stamenkovic, I.13
-
9
-
-
84890909489
-
Cancer stem cells in pediatric sarcomas
-
Dela Cruz FS. Cancer stem cells in pediatric sarcomas. Front Oncol. 2013; 3: 168.
-
(2013)
Front Oncol.
, vol.3
, pp. 168
-
-
Dela Cruz, F.S.1
-
11
-
-
70149105476
-
Ewing's sarcoma: standard and experimental treatment options
-
Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Ewing's sarcoma: standard and experimental treatment options. Curr Treat Options Oncol. 2009; 10: 126-140.
-
(2009)
Curr Treat Options Oncol.
, vol.10
, pp. 126-140
-
-
Subbiah, V.1
Anderson, P.2
Lazar, A.J.3
Burdett, E.4
Raymond, K.5
Ludwig, J.A.6
-
12
-
-
36849016900
-
Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells
-
Sonnemann J, Dreyer L, Hartwig M, Palani CD, Hong le TT, Klier U, Broker B, Volker U, Beck JF. Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells. J Cancer Res Clin Oncol. 2007; 133: 847-858.
-
(2007)
J Cancer Res Clin Oncol.
, vol.133
, pp. 847-858
-
-
Sonnemann, J.1
Dreyer, L.2
Hartwig, M.3
Palani, C.D.4
Hong le, T.T.5
Klier, U.6
Broker, B.7
Volker, U.8
Beck, J.F.9
-
13
-
-
40849114332
-
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy
-
Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, et al. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer. 2008; 44: 699-709.
-
(2008)
Eur J Cancer.
, vol.44
, pp. 699-709
-
-
Schaefer, K.L.1
Eisenacher, M.2
Braun, Y.3
Brachwitz, K.4
Wai, D.H.5
Dirksen, U.6
Lanvers-Kaminsky, C.7
Juergens, H.8
Herrero, D.9
Stegmaier, S.10
Koscielniak, E.11
Eggert, A.12
Nathrath, M.13
-
14
-
-
77953713665
-
The molecular pathogenesis of Ewing's sarcoma
-
Mackintosh C, Madoz-Gurpide J, Ordonez JL, Osuna D, Herrero-Martin D. The molecular pathogenesis of Ewing's sarcoma. Cancer Biol Ther. 2010; 9: 655-667.
-
(2010)
Cancer Biol Ther.
, vol.9
, pp. 655-667
-
-
Mackintosh, C.1
Madoz-Gurpide, J.2
Ordonez, J.L.3
Osuna, D.4
Herrero-Martin, D.5
-
15
-
-
84856732824
-
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
-
Nakatani F, Ferracin M, Manara MC, Ventura S, Del Monaco V, Ferrari S, Alberghini M, Grilli A, Knuutila S, Schaefer KL, Mattia G, Negrini M, Picci P, et al. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy. J Pathol. 2012; 226: 796-805.
-
(2012)
J Pathol.
, vol.226
, pp. 796-805
-
-
Nakatani, F.1
Ferracin, M.2
Manara, M.C.3
Ventura, S.4
Del Monaco, V.5
Ferrari, S.6
Alberghini, M.7
Grilli, A.8
Knuutila, S.9
Schaefer, K.L.10
Mattia, G.11
Negrini, M.12
Picci, P.13
-
16
-
-
84874449515
-
miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor
-
Iida K, Fukushi J, Matsumoto Y, Oda Y, Takahashi Y, Fujiwara T, Fujiwara-Okada Y, Hatano M, Nabashima A, Kamura S, Iwamoto Y. miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor. Cancer Cell Int. 2013; 13: 21.
-
(2013)
Cancer Cell Int.
, vol.13
, pp. 21
-
-
Iida, K.1
Fukushi, J.2
Matsumoto, Y.3
Oda, Y.4
Takahashi, Y.5
Fujiwara, T.6
Fujiwara-Okada, Y.7
Hatano, M.8
Nabashima, A.9
Kamura, S.10
Iwamoto, Y.11
-
17
-
-
84890682112
-
How to target apoptosis signaling pathways for the treatment of pediatric cancers
-
Fulda S. How to target apoptosis signaling pathways for the treatment of pediatric cancers. Front Oncol. 2013; 3: 22.
-
(2013)
Front Oncol.
, vol.3
, pp. 22
-
-
Fulda, S.1
-
18
-
-
0036783411
-
Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (Edelfosine), a proapoptotic agent in tumor cells
-
Gajate C, Mollinedo F. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (Edelfosine), a proapoptotic agent in tumor cells. Curr Drug Metab. 2002; 3: 491-525.
-
(2002)
Curr Drug Metab.
, vol.3
, pp. 491-525
-
-
Gajate, C.1
Mollinedo, F.2
-
19
-
-
9144229513
-
ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor
-
Mollinedo F, Gajate C, Martin-Santamaria S, Gago F. ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor. Curr Med Chem. 2004; 11: 3163-3184.
-
(2004)
Curr Med Chem.
, vol.11
, pp. 3163-3184
-
-
Mollinedo, F.1
Gajate, C.2
Martin-Santamaria, S.3
Gago, F.4
-
20
-
-
52949108830
-
Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects
-
van Blitterswijk WJ, Verheij M. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr Pharm Des. 2008; 14: 2061-2074.
-
(2008)
Curr Pharm Des.
, vol.14
, pp. 2061-2074
-
-
van Blitterswijk, W.J.1
Verheij, M.2
-
21
-
-
84908122155
-
Editorial: Antitumor alkylphospholipid analogs: a promising and growing family of synthetic cell membrane-targeting molecules for cancer treatment
-
Mollinedo F. Editorial: Antitumor alkylphospholipid analogs: a promising and growing family of synthetic cell membrane-targeting molecules for cancer treatment. Anticancer Agents Med Chem. 2014; 14: 495-498.
-
(2014)
Anticancer Agents Med Chem.
, vol.14
, pp. 495-498
-
-
Mollinedo, F.1
-
22
-
-
0035503414
-
Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer
-
Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, Mansi J. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol. 2001; 19: 4150-4159.
-
(2001)
J Clin Oncol.
, vol.19
, pp. 4150-4159
-
-
Leonard, R.1
Hardy, J.2
van Tienhoven, G.3
Houston, S.4
Simmonds, P.5
David, M.6
Mansi, J.7
-
23
-
-
34147130359
-
Antitumor ether lipids: proapoptotic agents with multiple therapeutic indications
-
Mollinedo F. Antitumor ether lipids: proapoptotic agents with multiple therapeutic indications. Expert Opin Ther Patents. 2007; 17: 385-405.
-
(2007)
Expert Opin Ther Patents.
, vol.17
, pp. 385-405
-
-
Mollinedo, F.1
-
24
-
-
84907509887
-
Current view on the mechanism of action of perifosine in cancer
-
Fensterle J, Aicher B, Seipelt I, Teifel M, Engel J. Current view on the mechanism of action of perifosine in cancer. Anticancer Agents Med Chem. 2014; 14: 629-635.
-
(2014)
Anticancer Agents Med Chem.
, vol.14
, pp. 629-635
-
-
Fensterle, J.1
Aicher, B.2
Seipelt, I.3
Teifel, M.4
Engel, J.5
-
25
-
-
1842290345
-
Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL
-
Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, Modolell M. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL. Cancer Res. 1997; 57: 1320-1328.
-
(1997)
Cancer Res.
, vol.57
, pp. 1320-1328
-
-
Mollinedo, F.1
Fernandez-Luna, J.L.2
Gajate, C.3
Martin-Martin, B.4
Benito, A.5
Martinez-Dalmau, R.6
Modolell, M.7
-
26
-
-
0033974266
-
Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis
-
Gajate C, Fonteriz RI, Cabaner C, Alvarez-Noves G, Alvarez-Rodriguez Y, Modolell M, Mollinedo F. Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis. Int J Cancer. 2000; 85: 674-682.
-
(2000)
Int J Cancer.
, vol.85
, pp. 674-682
-
-
Gajate, C.1
Fonteriz, R.I.2
Cabaner, C.3
Alvarez-Noves, G.4
Alvarez-Rodriguez, Y.5
Modolell, M.6
Mollinedo, F.7
-
27
-
-
33846243705
-
Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts
-
Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007; 109: 711-719.
-
(2007)
Blood.
, vol.109
, pp. 711-719
-
-
Gajate, C.1
Mollinedo, F.2
-
28
-
-
77954237062
-
Lipid raft-targeted therapy in multiple myeloma
-
Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, Blanco-Prieto MJ. Lipid raft-targeted therapy in multiple myeloma. Oncogene. 2010; 29: 3748-3757.
-
(2010)
Oncogene.
, vol.29
, pp. 3748-3757
-
-
Mollinedo, F.1
de la Iglesia-Vicente, J.2
Gajate, C.3
Estella-Hermoso de Mendoza, A.4
Villa-Pulgarin, J.A.5
Campanero, M.A.6
Blanco-Prieto, M.J.7
-
29
-
-
77950641684
-
In vitro and in vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts
-
Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, Roue G, Gil J, Colomer D, Campanero MA, Blanco-Prieto MJ. In vitro and in vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin Cancer Res. 2010; 16: 2046-2054.
-
(2010)
Clin Cancer Res.
, vol.16
, pp. 2046-2054
-
-
Mollinedo, F.1
de la Iglesia-Vicente, J.2
Gajate, C.3
Estella-Hermoso de Mendoza, A.4
Villa-Pulgarin, J.A.5
de Frias, M.6
Roue, G.7
Gil, J.8
Colomer, D.9
Campanero, M.A.10
Blanco-Prieto, M.J.11
-
30
-
-
3543078747
-
Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis
-
Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, Santos-Beneit AM, Veldman RJ, Mollinedo F. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med. 2004; 200: 353-365.
-
(2004)
J Exp Med.
, vol.200
, pp. 353-365
-
-
Gajate, C.1
Del Canto-Janez, E.2
Acuna, A.U.3
Amat-Guerri, F.4
Geijo, E.5
Santos-Beneit, A.M.6
Veldman, R.J.7
Mollinedo, F.8
-
31
-
-
64549139703
-
Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells
-
Gajate C, Gonzalez-Camacho F, Mollinedo F. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS ONE. 2009; 4: e5044.
-
(2009)
PLoS ONE.
, vol.4
, pp. e5044
-
-
Gajate, C.1
Gonzalez-Camacho, F.2
Mollinedo, F.3
-
32
-
-
0035895097
-
The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells
-
Gajate C, Mollinedo F. The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood. 2001; 98: 3860-3863.
-
(2001)
Blood.
, vol.98
, pp. 3860-3863
-
-
Gajate, C.1
Mollinedo, F.2
-
33
-
-
77952487833
-
Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy
-
Mollinedo F, Gajate C. Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy. Future Oncol. 2010; 6: 811-821.
-
(2010)
Future Oncol.
, vol.6
, pp. 811-821
-
-
Mollinedo, F.1
Gajate, C.2
-
34
-
-
84908121687
-
Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine
-
Gajate C, Mollinedo F. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine. Anticancer Agents Med Chem. 2014; 14: 509-527.
-
(2014)
Anticancer Agents Med Chem.
, vol.14
, pp. 509-527
-
-
Gajate, C.1
Mollinedo, F.2
-
35
-
-
84861220296
-
Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum
-
Gajate C, Matos-da-Silva M, Dakir EL, Fonteriz RI, Alvarez J, Mollinedo F. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum. Oncogene. 2012; 31: 2627-2639.
-
(2012)
Oncogene.
, vol.31
, pp. 2627-2639
-
-
Gajate, C.1
Matos-da-Silva, M.2
Dakir, E.L.3
Fonteriz, R.I.4
Alvarez, J.5
Mollinedo, F.6
-
36
-
-
35948946873
-
Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells
-
Nieto-Miguel T, Fonteriz RI, Vay L, Gajate C, Lopez-Hernandez S, Mollinedo F. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res. 2007; 67: 10368-10378.
-
(2007)
Cancer Res.
, vol.67
, pp. 10368-10378
-
-
Nieto-Miguel, T.1
Fonteriz, R.I.2
Vay, L.3
Gajate, C.4
Lopez-Hernandez, S.5
Mollinedo, F.6
-
37
-
-
61349112191
-
Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice
-
Estella-Hermoso de Mendoza A, Campanero MA, de la Iglesia-Vicente J, Gajate C, Mollinedo F, Blanco-Prieto MJ. Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice. Clin Cancer Res. 2009; 15: 858-864.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 858-864
-
-
Estella-Hermoso de Mendoza, A.1
Campanero, M.A.2
de la Iglesia-Vicente, J.3
Gajate, C.4
Mollinedo, F.5
Blanco-Prieto, M.J.6
-
38
-
-
0031968488
-
Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
-
Gajate C, Santos-Beneit A, Modolell M, Mollinedo F. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Mol Pharmacol. 1998; 53: 602-612.
-
(1998)
Mol Pharmacol.
, vol.53
, pp. 602-612
-
-
Gajate, C.1
Santos-Beneit, A.2
Modolell, M.3
Mollinedo, F.4
-
39
-
-
0028947930
-
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
-
Harris SA, Enger RJ, Riggs BL, Spelsberg TC. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res. 1995; 10: 178-186.
-
(1995)
J Bone Miner Res.
, vol.10
, pp. 178-186
-
-
Harris, S.A.1
Enger, R.J.2
Riggs, B.L.3
Spelsberg, T.C.4
-
40
-
-
0036354866
-
Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization
-
Subramaniam M, Jalal SM, Rickard DJ, Harris SA, Bolander ME, Spelsberg TC. Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization. J Cell Biochem. 2002; 87: 9-15.
-
(2002)
J Cell Biochem.
, vol.87
, pp. 9-15
-
-
Subramaniam, M.1
Jalal, S.M.2
Rickard, D.J.3
Harris, S.A.4
Bolander, M.E.5
Spelsberg, T.C.6
-
41
-
-
84875474914
-
Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast
-
Cuesta-Marban A, Botet J, Czyz O, Cacharro LM, Gajate C, Hornillos V, Delgado J, Zhang H, Amat-Guerri F, Acuna AU, McMaster CR, Revuelta JL, Zaremberg V, et al. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast. J Biol Chem. 2013; 288: 8405-8418.
-
(2013)
J Biol Chem.
, vol.288
, pp. 8405-8418
-
-
Cuesta-Marban, A.1
Botet, J.2
Czyz, O.3
Cacharro, L.M.4
Gajate, C.5
Hornillos, V.6
Delgado, J.7
Zhang, H.8
Amat-Guerri, F.9
Acuna, A.U.10
McMaster, C.R.11
Revuelta, J.L.12
Zaremberg, V.13
-
42
-
-
79959971349
-
Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria
-
Mollinedo F, Fernandez M, Hornillos V, Delgado J, Amat-Guerri F, Acuna AU, Nieto-Miguel T, Villa-Pulgarin JA, Gonzalez-Garcia C, Cena V, Gajate C. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis. 2011; 2: e158.
-
(2011)
Cell Death Dis.
, vol.2
, pp. e158
-
-
Mollinedo, F.1
Fernandez, M.2
Hornillos, V.3
Delgado, J.4
Amat-Guerri, F.5
Acuna, A.U.6
Nieto-Miguel, T.7
Villa-Pulgarin, J.A.8
Gonzalez-Garcia, C.9
Cena, V.10
Gajate, C.11
-
43
-
-
14744281338
-
Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum
-
Klee M, Pimentel-Muinos FX. Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum. J Cell Biol. 2005; 168: 723-734.
-
(2005)
J Cell Biol.
, vol.168
, pp. 723-734
-
-
Klee, M.1
Pimentel-Muinos, F.X.2
-
44
-
-
0037417334
-
Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol
-
Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol. 2003; 160: 1115-1127.
-
(2003)
J Cell Biol.
, vol.160
, pp. 1115-1127
-
-
Breckenridge, D.G.1
Stojanovic, M.2
Marcellus, R.C.3
Shore, G.C.4
-
45
-
-
33646171070
-
Stress induction of GRP78/BiP and its role in cancer
-
Li J, Lee AS. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med. 2006; 6: 45-54.
-
(2006)
Curr Mol Med.
, vol.6
, pp. 45-54
-
-
Li, J.1
Lee, A.S.2
-
46
-
-
0034015954
-
Chemical and physiological characterization of fluo-4 Ca2+-indicator dyes
-
Gee KR, Brown KA, Chen WN, Bishop-Stewart J, Gray D, Johnson I. Chemical and physiological characterization of fluo-4 Ca2+-indicator dyes. Cell Calcium. 2000; 27: 97-106.
-
(2000)
Cell Calcium.
, vol.27
, pp. 97-106
-
-
Gee, K.R.1
Brown, K.A.2
Chen, W.N.3
Bishop-Stewart, J.4
Gray, D.5
Johnson, I.6
-
47
-
-
79551600416
-
Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction
-
Iwasawa R, Mahul-Mellier AL, Datler C, Pazarentzos E, Grimm S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J. 2011; 30: 556-568.
-
(2011)
EMBO J.
, vol.30
, pp. 556-568
-
-
Iwasawa, R.1
Mahul-Mellier, A.L.2
Datler, C.3
Pazarentzos, E.4
Grimm, S.5
-
48
-
-
0036606540
-
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
-
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002; 16: 1345-1355.
-
(2002)
Genes Dev.
, vol.16
, pp. 1345-1355
-
-
Nishitoh, H.1
Matsuzawa, A.2
Tobiume, K.3
Saegusa, K.4
Takeda, K.5
Inoue, K.6
Hori, S.7
Kakizuka, A.8
Ichijo, H.9
-
49
-
-
0037456435
-
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
-
Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003; 348: 694-701.
-
(2003)
N Engl J Med.
, vol.348
, pp. 694-701
-
-
Grier, H.E.1
Krailo, M.D.2
Tarbell, N.J.3
Link, M.P.4
Fryer, C.J.5
Pritchard, D.J.6
Gebhardt, M.C.7
Dickman, P.S.8
Perlman, E.J.9
Meyers, P.A.10
Donaldson, S.S.11
Moore, S.12
Rausen, A.R.13
-
50
-
-
84931023434
-
Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas
-
Whelan J, Khan A, Sharma A, Rothermundt C, Dileo P, Michelagnoli M, Seddon B, Strausss S. Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas. Clin Sarcoma Res. 2012; 2: 12.
-
(2012)
Clin Sarcoma Res.
, vol.2
, pp. 12
-
-
Whelan, J.1
Khan, A.2
Sharma, A.3
Rothermundt, C.4
Dileo, P.5
Michelagnoli, M.6
Seddon, B.7
Strausss, S.8
-
51
-
-
0141996464
-
Microtubules, microtubuleinterfering agents and apoptosis
-
Mollinedo F, Gajate C. Microtubules, microtubuleinterfering agents and apoptosis. Apoptosis. 2003; 8: 413-450.
-
(2003)
Apoptosis.
, vol.8
, pp. 413-450
-
-
Mollinedo, F.1
Gajate, C.2
-
52
-
-
14544274160
-
Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs
-
Mollinedo F. Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs. IDrugs. 2005; 8: 127-143.
-
(2005)
IDrugs.
, vol.8
, pp. 127-143
-
-
Mollinedo, F.1
-
53
-
-
84871711842
-
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
-
Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013; 65: 157-170.
-
(2013)
J Pharm Pharmacol.
, vol.65
, pp. 157-170
-
-
Tacar, O.1
Sriamornsak, P.2
Dass, C.R.3
-
55
-
-
84926662707
-
Metformin, an old drug, brings a new era to cancer therapy
-
He H, Ke R, Lin H, Ying Y, Liu D, Luo Z. Metformin, an old drug, brings a new era to cancer therapy. Cancer J. 2015; 21: 70-74.
-
(2015)
Cancer J.
, vol.21
, pp. 70-74
-
-
He, H.1
Ke, R.2
Lin, H.3
Ying, Y.4
Liu, D.5
Luo, Z.6
-
56
-
-
79952348567
-
Caspase-4 directly activates caspase-9 in endoplasmic reticulum stress-induced apoptosis in SHSY5Y cells
-
Yamamuro A, Kishino T, Ohshima Y, Yoshioka Y, Kimura T, Kasai A, Maeda S. Caspase-4 directly activates caspase-9 in endoplasmic reticulum stress-induced apoptosis in SHSY5Y cells. J Pharmacol Sci. 2011; 115: 239-243.
-
(2011)
J Pharmacol Sci.
, vol.115
, pp. 239-243
-
-
Yamamuro, A.1
Kishino, T.2
Ohshima, Y.3
Yoshioka, Y.4
Kimura, T.5
Kasai, A.6
Maeda, S.7
-
57
-
-
59449110529
-
Targeting the apoptosome for cancer therapy
-
Ledgerwood EC, Morison IM. Targeting the apoptosome for cancer therapy. Clin Cancer Res. 2009; 15: 420-424.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 420-424
-
-
Ledgerwood, E.C.1
Morison, I.M.2
-
58
-
-
84874275540
-
Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy?
-
Yao C, Wei JJ, Wang ZY, Ding HM, Li D, Yan SC, Yang YJ, Gu ZP. Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy? Cell Biochem Biophys. 2013; 65: 217-227.
-
(2013)
Cell Biochem Biophys.
, vol.65
, pp. 217-227
-
-
Yao, C.1
Wei, J.J.2
Wang, Z.Y.3
Ding, H.M.4
Li, D.5
Yan, S.C.6
Yang, Y.J.7
Gu, Z.P.8
-
59
-
-
33751002361
-
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma
-
Bailey HH, Mahoney MR, Ettinger DS, Maples WJ, Fracasso PM, Traynor AM, Erlichman C, Okuno SH. Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma. Cancer. 2006; 107: 2462-2467.
-
(2006)
Cancer.
, vol.107
, pp. 2462-2467
-
-
Bailey, H.H.1
Mahoney, M.R.2
Ettinger, D.S.3
Maples, W.J.4
Fracasso, P.M.5
Traynor, A.M.6
Erlichman, C.7
Okuno, S.H.8
-
60
-
-
33745055718
-
A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial
-
Knowling M, Blackstein M, Tozer R, Bramwell V, Dancey J, Dore N, Matthews S, Eisenhauer E. A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs. 2006; 24: 435-439.
-
(2006)
Invest New Drugs.
, vol.24
, pp. 435-439
-
-
Knowling, M.1
Blackstein, M.2
Tozer, R.3
Bramwell, V.4
Dancey, J.5
Dore, N.6
Matthews, S.7
Eisenhauer, E.8
-
61
-
-
65649108410
-
Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis
-
Mollinedo F, Gajate C, Morales AI, del Canto-Janez E, Justies N, Collia F, Rivas JV, Modolell M, Iglesias A. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis. J Pharmacol Exp Ther. 2009; 329: 439-449.
-
(2009)
J Pharmacol Exp Ther.
, vol.329
, pp. 439-449
-
-
Mollinedo, F.1
Gajate, C.2
Morales, A.I.3
del Canto-Janez, E.4
Justies, N.5
Collia, F.6
Rivas, J.V.7
Modolell, M.8
Iglesias, A.9
-
62
-
-
84857975015
-
Metformin: multi-faceted protection against cancer
-
Del Barco S, Vazquez-Martin A, Cufi S, Oliveras-Ferraros C, Bosch-Barrera J, Joven J, Martin-Castillo B, Menendez JA. Metformin: multi-faceted protection against cancer. Oncotarget. 2011; 2: 896-917.
-
(2011)
Oncotarget.
, vol.2
, pp. 896-917
-
-
Del Barco, S.1
Vazquez-Martin, A.2
Cufi, S.3
Oliveras-Ferraros, C.4
Bosch-Barrera, J.5
Joven, J.6
Martin-Castillo, B.7
Menendez, J.A.8
-
63
-
-
84884211823
-
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
-
Pierotti MA, Berrino F, Gariboldi M, Melani C, Mogavero A, Negri T, Pasanisi P, Pilotti S. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene. 2013; 32: 1475-1487.
-
(2013)
Oncogene.
, vol.32
, pp. 1475-1487
-
-
Pierotti, M.A.1
Berrino, F.2
Gariboldi, M.3
Melani, C.4
Mogavero, A.5
Negri, T.6
Pasanisi, P.7
Pilotti, S.8
-
64
-
-
84917706446
-
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
-
Gritti M, Wurth R, Angelini M, Barbieri F, Peretti M, Pizzi E, Pattarozzi A, Carra E, Sirito R, Daga A, Curmi PM, Mazzanti M, Florio T. Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current. Oncotarget. 2014; 5: 11252-11268.
-
(2014)
Oncotarget.
, vol.5
, pp. 11252-11268
-
-
Gritti, M.1
Wurth, R.2
Angelini, M.3
Barbieri, F.4
Peretti, M.5
Pizzi, E.6
Pattarozzi, A.7
Carra, E.8
Sirito, R.9
Daga, A.10
Curmi, P.M.11
Mazzanti, M.12
Florio, T.13
-
65
-
-
84891956900
-
Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation
-
Quattrini I, Conti A, Pazzaglia L, Novello C, Ferrari S, Picci P, Benassi MS. Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. Oncol Rep. 2014; 31: 370-375.
-
(2014)
Oncol Rep.
, vol.31
, pp. 370-375
-
-
Quattrini, I.1
Conti, A.2
Pazzaglia, L.3
Novello, C.4
Ferrari, S.5
Picci, P.6
Benassi, M.S.7
-
66
-
-
84864536555
-
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
-
Cufi S, Corominas-Faja B, Vazquez-Martin A, Oliveras-Ferraros C, Dorca J, Bosch-Barrera J, Martin-Castillo B, Menendez JA. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget. 2012; 3: 395-398.
-
(2012)
Oncotarget.
, vol.3
, pp. 395-398
-
-
Cufi, S.1
Corominas-Faja, B.2
Vazquez-Martin, A.3
Oliveras-Ferraros, C.4
Dorca, J.5
Bosch-Barrera, J.6
Martin-Castillo, B.7
Menendez, J.A.8
-
67
-
-
84879867265
-
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines
-
Morgillo F, Sasso FC, Della Corte CM, Vitagliano D, D'Aiuto E, Troiani T, Martinelli E, De Vita F, Orditura M, De Palma R, Ciardiello F. Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines. Clin Cancer Res. 2013; 19: 3508-3519.
-
(2013)
Clin Cancer Res.
, vol.19
, pp. 3508-3519
-
-
Morgillo, F.1
Sasso, F.C.2
Della Corte, C.M.3
Vitagliano, D.4
D'Aiuto, E.5
Troiani, T.6
Martinelli, E.7
De Vita, F.8
Orditura, M.9
De Palma, R.10
Ciardiello, F.11
-
68
-
-
84893841404
-
Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
-
Lin YC, Wu MH, Wei TT, Huang WC, Huang LY, Lin YT, Chen CC. Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress. Oncotarget. 2014; 5: 298-308.
-
(2014)
Oncotarget.
, vol.5
, pp. 298-308
-
-
Lin, Y.C.1
Wu, M.H.2
Wei, T.T.3
Huang, W.C.4
Huang, L.Y.5
Lin, Y.T.6
Chen, C.C.7
-
69
-
-
84921711858
-
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
-
Vujic I, Sanlorenzo M, Posch C, Esteve-Puig R, Yen AJ, Kwong A, Tsumura A, Murphy R, Rappersberger K, Ortiz-Urda S. Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer. Oncotarget. 2015; 6: 969-978.
-
(2015)
Oncotarget.
, vol.6
, pp. 969-978
-
-
Vujic, I.1
Sanlorenzo, M.2
Posch, C.3
Esteve-Puig, R.4
Yen, A.J.5
Kwong, A.6
Tsumura, A.7
Murphy, R.8
Rappersberger, K.9
Ortiz-Urda, S.10
-
70
-
-
84919459438
-
Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models
-
Zi FM, He JS, Li Y, Wu C, Yang L, Yang Y, Wang LJ, He DH, Zhao Y, Wu WJ, Zheng GF, Han XY, Huang H, et al. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models. Cancer Lett. 2015; 356: 443-453.
-
(2015)
Cancer Lett.
, vol.356
, pp. 443-453
-
-
Zi, F.M.1
He, J.S.2
Li, Y.3
Wu, C.4
Yang, L.5
Yang, Y.6
Wang, L.J.7
He, D.H.8
Zhao, Y.9
Wu, W.J.10
Zheng, G.F.11
Han, X.Y.12
Huang, H.13
-
71
-
-
0027280181
-
Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3
-
Mollinedo F, Martinez-Dalmau R, Modolell M. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3. Biochem Biophys Res Commun. 1993; 192: 603-609.
-
(1993)
Biochem Biophys Res Commun.
, vol.192
, pp. 603-609
-
-
Mollinedo, F.1
Martinez-Dalmau, R.2
Modolell, M.3
-
72
-
-
0034657265
-
Induction of apoptosis in leukemic cells by the reversible microtubuledisrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-XL and cell cycle arrest
-
Gajate C, Barasoain I, Andreu JM, Mollinedo F. Induction of apoptosis in leukemic cells by the reversible microtubuledisrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-XL and cell cycle arrest. Cancer Res. 2000; 60: 2651-2659.
-
(2000)
Cancer Res.
, vol.60
, pp. 2651-2659
-
-
Gajate, C.1
Barasoain, I.2
Andreu, J.M.3
Mollinedo, F.4
-
73
-
-
0037388458
-
Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95-and mitochondrial-mediated mechanism
-
Gajate C, An F, Mollinedo F. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95-and mitochondrial-mediated mechanism. Clin Cancer Res. 2003; 9: 1535-1545.
-
(2003)
Clin Cancer Res.
, vol.9
, pp. 1535-1545
-
-
Gajate, C.1
An, F.2
Mollinedo, F.3
-
74
-
-
0034038174
-
Involvement of mitochondria and caspase-3 in ET-18-OCH3-induced apoptosis of human leukemic cells
-
Gajate C, Santos-Beneit AM, Macho A, Lazaro M, Hernandez-De Rojas A, Modolell M, Munoz E, Mollinedo F. Involvement of mitochondria and caspase-3 in ET-18-OCH3-induced apoptosis of human leukemic cells. Int J Cancer. 2000; 86: 208-218.
-
(2000)
Int J Cancer.
, vol.86
, pp. 208-218
-
-
Gajate, C.1
Santos-Beneit, A.M.2
Macho, A.3
Lazaro, M.4
Hernandez-De Rojas, A.5
Modolell, M.6
Munoz, E.7
Mollinedo, F.8
|